Company record
Unichem Pharmaceuticals USA Inc.
0 FDA warning letters since 2023 and 3 recalls in the last 12 months.
Get an email the day FDA posts anything new about Unichem Pharmaceuticals USA Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| May 13 | Class III | Unichem Pharmaceuticals USA Inc. Drug |
busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by Unichem Laboratories LTD., Ind, Area, Meerut Road, Ghazibad - 201 003, India Manufactured for: Unichem Pharmaceuticals (USA), Inc. Ea… Subpotent drug |
| Feb 18 | Class III | Unichem Pharmaceuticals USA Inc. Drug |
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories… Tablets/Capsules Imprinted with Wrong ID |
| Feb 11 | Class II | Unichem Pharmaceuticals USA Inc. Drug |
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: … cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits. |